Claraphi Advisory Network’s Innovator IBD ETF Leaders ETF LDRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-10,850
Closed -$276K 289
2018
Q3
$276K Sell
10,850
-165
-1% -$4.19K 0.15% 187
2018
Q2
$278K Buy
11,015
+485
+5% +$12K 0.18% 168
2018
Q1
$259K Buy
+10,530
New +$271K 0.18% 177

Other funds holding LDRS

Claraphi Advisory Network's LDRS Position: Q4 2018 in Review

Claraphi Advisory Network sold out of Innovator IBD ETF Leaders ETF (LDRS) in Q4 2018, closing a stake of 10,850 shares — an estimated $276K sold.

Claraphi Advisory Network first reported a position in LDRS in Q1 2018 and held it in 3 quarters. The position peaked at $278K in Q2 2018. 13 funds tracked by Wall St. Rank hold LDRS as of Q4 2018.

  • Claraphi Advisory Network reported no remaining Innovator IBD ETF Leaders ETF position as of Q4 2018 after selling out during the quarter.
  • Claraphi Advisory Network sold 10,850 Innovator IBD ETF Leaders ETF shares in Q4 2018, an estimated $276K.
  • Claraphi Advisory Network first reported a position in Innovator IBD ETF Leaders ETF in Q1 2018 and held it in 3 quarters.
  • Claraphi Advisory Network's Innovator IBD ETF Leaders ETF position peaked at $278K in Q2 2018.
  • 13 funds tracked by Wall St. Rank held Innovator IBD ETF Leaders ETF as of Q4 2018.

Based on Claraphi Advisory Network's 13F filing for Q4 2018, filed 12 Feb 2019.